What are the primary types of Congenital Adrenal Hyperplasia (CAH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Congenital Adrenal Hyperplasia

Congenital adrenal hyperplasia comprises several distinct enzyme deficiency disorders, with 21-hydroxylase deficiency accounting for over 90-95% of all cases, followed by 11β-hydroxylase deficiency as the second most common type, and rare forms including 3β-hydroxysteroid dehydrogenase deficiency, 17-hydroxylase deficiency, and lipoid CAH. 1, 2, 3

Primary Types by Frequency

21-Hydroxylase Deficiency (>90-95% of cases)

  • Classic forms present in two variants: salt-wasting (approximately 75% of classic cases) with both cortisol and aldosterone deficiency leading to hypovolemia and shock, and simple virilizing type with cortisol deficiency but preserved aldosterone production 3, 4

  • Non-classic form presents later in childhood or adulthood with symptoms of premature adrenarche, growth acceleration, hirsutism, and irregular menses 1

  • Caused by mutations in the CYP21 (CYP21A2) gene, with most mutations arising from recombination between CYP21 and the nearby pseudogene CYP21P 3

  • Newborn screening with elevated 17-hydroxyprogesterone levels enables early diagnosis in the United States 1

11β-Hydroxylase Deficiency (Second most common)

  • Results from CYP11B1 deficiency causing inability to produce cortisol and aldosterone with excessive adrenal androgen production 2

  • Key distinguishing feature: Unlike 21-hydroxylase deficiency, mineralocorticoid deficiency findings are NOT observed despite the biochemical aldosterone deficiency 2

  • Clinical and laboratory features otherwise resemble 21-hydroxylase deficiency with virilization 2

Rare Forms (<1% combined)

3β-Hydroxysteroid Dehydrogenase Deficiency:

  • Incidence less than 1/1,000 live births 2
  • Impairs both adrenal and gonadal steroid biosynthesis very early in the steroidogenic pathway 2
  • Presents with inadequate virilization in 46,XY individuals and varying degrees of virilization in 46,XX individuals 2
  • May manifest as salt-wasting crisis in infancy or delayed puberty in both sexes 2

17-Hydroxylase Deficiency:

  • Characterized by 46,XY disorders of sex development in genetic males 2
  • Genetic females present with immature pubertal development and primary amenorrhea due to estrogen deficiency throughout adolescence 2

Lipoid CAH (Steroidogenic Acute Regulatory Protein Deficiency):

  • Typically presents with salt wasting in the first year of life 2
  • Complete or near-complete deficiency of all adrenal and gonadal steroid hormones 2
  • Progressive accumulation of cholesterol esters in the adrenal gland is pathognomonic 2

Classification Context

When evaluating primary adrenal insufficiency, CAH represents one category within the broader genetic causes listed in diagnostic algorithms 5

The etiologic workup distinguishes CAH from other causes of primary adrenal insufficiency including autoimmune disease (85% of adult cases in Western Europe), infections, bleeding, and other genetic disorders like adrenoleukodystrophy 5

Clinical Implications

  • Phenotype generally correlates with genotype in 21-hydroxylase deficiency, allowing prognostic information from genetic testing 3

  • All classic CAH patients require lifelong glucocorticoid replacement (typically hydrocortisone in children), with most also requiring mineralocorticoid (fludrocortisone) 1, 3

  • Long-term comorbidities include cardiometabolic risk factors, impaired cognitive function, adrenal rest tumors, and bone health effects, necessitating ongoing monitoring 1, 6

References

Research

Congenital Adrenal Hyperplasia.

Pediatrics in review, 2024

Research

Rare Types of Congenital Adrenal Hyperplasias Other Than 21-hydroxylase Deficiency.

Journal of clinical research in pediatric endocrinology, 2025

Research

Classic congenital adrenal hyperplasia: A delayed presentation.

Pakistan journal of medical sciences, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the symptoms and treatment options for Congenital Adrenal Hyperplasia (CAH) in infants and children?
What are the symptoms of Congenital Adrenal Hyperplasia (CAH)?
What are the symptoms and treatment of Congenital Adrenal Hyperplasia (CAH)?
What are the typical lab findings in congenital adrenal hyperplasia (CAH)?
What tests are usually ordered to monitor Congenital Adrenal Hyperplasia (CAH) in adults?
What are the sequelae of healed granulomatous disease, such as tuberculosis or histoplasmosis, in the lung?
Is cataract extraction with intraocular lens (IOL) implant medically necessary for a 39-year-old patient with significant visual impairment, 20/200 visual acuity, and advanced cataract opacification in the right eye, who has a history of previous cataract surgery in the left eye with a posterior chamber IOL and open posterior capsule?
What is the management approach for a woman of reproductive age with a history of smoking or autoimmune disorders diagnosed with chronic granulomatous mastitis?
What could be causing a late menstrual period in a female patient of reproductive age with negative pregnancy tests and potentially irregular menstrual cycles or underlying medical conditions such as Polycystic Ovary Syndrome (PCOS) or thyroid disorders?
What are the indications and guidelines for Endoscopic Retrograde Cholangiopancreatography (ERCP) in adult patients?
What are the long-term effects of healed granulomatous disease (inflammatory disease characterized by granulomas) in the lung on lung tissue and function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.